Medical disclaimer: This article is for informational purposes only. Always consult your GP or a registered healthcare provider about your specific situation.
Is Wegovy Available on the NHS in 2026?
Yes — but for most people, the practical answer is not yet, not easily, and not quickly.
Wegovy (semaglutide 2.4mg) is NICE-approved for NHS use in England. The guidance is real, the approval is real, and NHS funding exists. But the gap between NICE approval and actual patient access has been one of the most frustrating stories in UK healthcare over the past two years. Waiting lists of 12 to 18 months are common. Eligibility criteria are strict. And implementation across integrated care boards varies so significantly that your postcode can determine whether you wait one year or three.
This article explains exactly what NHS access looks like in 2026, who qualifies, what the process involves, and what your realistic options are if you cannot wait.
What NICE Says About Wegovy on the NHS
NICE issued Technology Appraisal guidance TA875 supporting the use of semaglutide 2.4mg (Wegovy) within NHS specialist weight management services. The key points of that guidance:
Wegovy is recommended for adults with a BMI of 35 or above and at least one weight-related health condition, OR for adults with a BMI of 30 or above who are referred from Tier 3 specialist weight management services in exceptional circumstances.
Treatment must be delivered alongside a reduced-calorie diet and increased physical activity as part of a specialist weight management programme — not as a standalone prescription.
NHS-funded treatment is limited to a maximum of two years. After that, continued treatment must be funded privately or through other means.
The guidance applies to England. Scotland, Wales, and Northern Ireland have their own separate medicines appraisal processes and coverage decisions.
The Reality: What NHS Access Actually Looks Like
NICE approval does not mean your GP can hand you a Wegovy prescription tomorrow. Here is the reality of the pathway:
Step 1 — GP referral. You need to ask your GP to refer you to a Tier 3 specialist weight management service. Your GP assesses whether you meet the referral criteria — BMI threshold plus comorbidities — and writes the referral.
Step 2 — Waiting list. You join the waiting list for your local Tier 3 service. In many areas this list is 12 to 18 months long. Some regions have paused new referrals entirely due to capacity pressures. The length of your wait depends heavily on where you live.
Step 3 — Tier 3 assessment. When you reach the front of the list, you are assessed by the specialist service. This involves a full clinical review, including your weight history, previous attempts at weight management, and any weight-related health conditions.
Step 4 — Treatment plan. If accepted into the programme, you receive Wegovy as part of a structured weight management programme including dietary support, physical activity guidance, and behavioural support. The medication is prescribed and dispensed through NHS channels.
NHS prescription cost: £9.90 per prescription item in England — the standard charge. Prescriptions are free in Scotland, Wales, and Northern Ireland. If you are on a low income or have a medical exemption, prescriptions may be free in England too.
Who Qualifies for NHS Wegovy?
The eligibility criteria for NHS-funded Wegovy are stricter than for private prescription. You generally need to meet all of the following:
A BMI of 35 or above with at least one significant weight-related health condition. Qualifying conditions include type 2 diabetes, hypertension, obstructive sleep apnoea, cardiovascular disease, or non-alcoholic fatty liver disease.
Evidence of previous attempts at weight management through lifestyle intervention. The NHS expects to see that you have genuinely tried diet and exercise changes before medication is considered.
Willingness to engage with an ongoing structured weight management programme alongside the medication.
In some areas and exceptional circumstances, NICE guidance allows referral for people with a BMI of 30 or above — but this is not standard, and most ICBs apply the BMI 35 threshold.
NHS Wegovy vs Private Wegovy: The Key Differences
NHS Wegovy: Cost to patient: £9.90/prescription in England, free elsewhere Wait time: 12–18+ months in most areas Eligibility: BMI ≥35 with comorbidities (strict) Duration: Maximum 2 years funded Support: Full Tier 3 multidisciplinary programme included Availability: Inconsistent across ICBs — postcode lottery
Private Wegovy: Cost to patient: £100–£299/month depending on dose and provider Wait time: Days — most online clinics approve within 24–48 hours Eligibility: BMI ≥30 (most providers) or BMI ≥27 with conditions Duration: No time limit Support: Varies by provider — best include ongoing clinical check-ins Availability: Nationwide through regulated online clinics
Scotland, Wales, and Northern Ireland
NHS coverage for Wegovy outside England works differently:
Scotland: The Scottish Medicines Consortium (SMC) has accepted Wegovy for use within NHS Scotland for weight management. Prescriptions are free. Access pathways are managed by individual NHS boards — contact your GP to understand the local pathway.
Wales: The All Wales Medicines Strategy Group (AWMSG) reviews medicines for NHS Wales. Check with your GP or health board for the current status of Wegovy access in your area.
Northern Ireland: The Medicines Optimisation Innovation Centre (MOIC) advises on medicines use in Northern Ireland. Prescriptions are free. Check with your GP regarding current access routes.
Can My GP Prescribe Wegovy Directly?
Currently, Wegovy on the NHS must be prescribed through specialist weight management services — your GP cannot simply write the prescription and send you to the pharmacy. This is one of the main bottlenecks in the system.
However, GP prescribing pathways are evolving. The NHS expanded Mounjaro (tirzepatide) GP prescribing from April 2026 through the QOF contract. A similar expansion for semaglutide in primary care has been discussed but has not yet been implemented at the time of writing. Check with your GP for the latest position in your area — this landscape is changing faster than any other area of NHS prescribing.
The Wegovy Pill: Coming to the NHS?
An oral version of Wegovy (semaglutide 25mg tablet) launched in early 2026. It contains the same active ingredient as injectable Wegovy but in daily pill form. NHS coverage for the oral version has not yet been announced — NICE would need to issue separate guidance for this formulation. Private prescribing of the oral tablet is available through some UK online clinics.
Should You Wait for the NHS or Go Private?
This is the question most people are actually trying to answer. Here is an honest framework:
Wait for the NHS if: You clearly meet the BMI ≥35 plus comorbidities criteria, you are not in urgent health need, you are comfortable with a 12–18 month wait, and you want the full Tier 3 multidisciplinary support programme. The NHS route also gives you clinical oversight from a specialist team, which is valuable for people with complex health situations.
Go private if: You want to start treatment now, you meet private eligibility criteria (BMI ≥30 or ≥27 with conditions) even if you may not meet the stricter NHS threshold, or you are in a region with particularly long NHS waiting lists. Private treatment from a regulated UK clinic is fully legal, uses the same licensed medications, and allows you to start within days.
Do both simultaneously: The smartest approach for many people is to go on the NHS waiting list while starting private treatment. If and when you reach the front of the NHS list, you can switch — having lost weight in the meantime may actually strengthen your case for ongoing NHS support. Discuss this strategy with your GP.
How to Start the NHS Process Today
Even if you plan to go private, getting on the NHS list costs nothing and makes sense given the long waits. Here is what to do:
Book an appointment with your GP and explain that you are interested in weight management medication. Mention that you have read about NICE guidance supporting Wegovy for people with BMI above 35 and weight-related health conditions.
Ask your GP to assess your eligibility for referral to the local Tier 3 weight management service. If you qualify, ask for the referral to be submitted promptly.
Record your starting BMI, weight, and any weight-related health conditions in writing. This documentation will be useful throughout the process.
Ask your GP about the NHS Mounjaro prescribing pathway — from June 2026, GPs can prescribe tirzepatide for obesity through the QOF scheme if your area is participating. This may offer a faster route than the Tier 3 pathway.
Private Clinics to Consider While You Wait
If you decide to start privately while on the NHS waiting list, these regulated UK clinics offer Wegovy on private prescription:
Levity UK — offers Wegovy, Ozempic, and Mounjaro with personalised clinical support. Available via Awin UK affiliate programme.
eMed UK — GLP-1 programme with unlimited GP consultations included. £100 flat-fee commission for affiliates.
Juniper UK — women-focused GLP-1 programme with dietitian support and an app. Part of the Eucalyptus group supporting 350,000+ patients globally.
Asda Online Doctor — major pharmacy offering competitive private prices for Mounjaro from approximately £149/month.
All of the above use GPhC-registered pharmacies and UK-registered prescribers. An online medical assessment is required before any prescription is issued.
Frequently Asked Questions
Is Wegovy free on the NHS? If you are prescribed Wegovy through an NHS Tier 3 weight management service, you pay the standard NHS prescription charge — currently £9.90 per item in England. Prescriptions are free in Scotland, Wales, and Northern Ireland. However, access is severely restricted and most people face long waiting lists.
How long is the waiting list for Wegovy on the NHS? Waiting lists vary by region but commonly extend to 12–18 months in England. Some areas have paused new referrals entirely. This is the single biggest reason most people opt for private treatment.
Can I get Wegovy on the NHS without being referred to a specialist? Not currently for Wegovy. NHS prescribing requires referral through Tier 3 specialist services. Mounjaro GP prescribing expanded in 2026 — ask your GP whether your area is participating in the new QOF pathway.
Does the NHS cover Wegovy for type 2 diabetes? Ozempic (semaglutide for diabetes) is what the NHS covers for type 2 diabetes — not Wegovy specifically. If you have type 2 diabetes, ask your GP about Ozempic on NHS prescription, which is more widely available through primary care.
What happens after 2 years of NHS Wegovy treatment? NICE guidance limits NHS-funded Wegovy to a maximum of 2 years. After that, continued treatment must be funded privately or you need to discuss alternative options with your clinical team.